This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: California Institute of Technology. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Dorte Renneberg: Innovator in DNA Recognition Technologies
Introduction
Dorte Renneberg is a prominent inventor based in Bern, Switzerland. She has made significant contributions to the field of DNA recognition through her innovative research and patented technologies. Her work focuses on developing methods and compositions that enhance the understanding and manipulation of genetic material.
Latest Patents
Dorte Renneberg holds a patent titled "Alternative heterocycles for DNA recognition." This patent describes methods and compositions for forming complexes between double-stranded DNA (dsDNA) and novel oligomers that comprise fused six-membered rings. By selecting appropriate target sequences and oligomers, her work enables the formation of oligomer-DNA complexes with high association constants. These complexes can be utilized for identifying specific dsDNA sequences, inhibiting gene transcription, and serving as therapeutic agents to inhibit the proliferation of undesired cells or modulate the expression of specific genes. She has 1 patent to her name.
Career Highlights
Dorte Renneberg is affiliated with the California Institute of Technology, where she continues her research and development in the field of molecular biology. Her innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Throughout her career, Dorte has collaborated with notable colleagues, including Christoph A Briehn and Philipp Weyermann. These partnerships have further advanced her research and contributed to the development of her patented technologies.
Conclusion
Dorte Renneberg is a trailblazer in the field of DNA recognition technologies. Her innovative work and patented inventions have the potential to significantly impact genetic research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
